Novo Nordisk A/S
DEEURNovo Nordisk A/S (US:NONOF) — Biotechnology: Pharmaceutical Preparations. Število borz, na katerih se trgujejo delnice družbe: 3. Na tej strani — cena in graf, dividende, največji imetniki in zgodovina števila delnic.
- Novo Nordisk A/S — NOVO-B · CO DK Registrska številka ni znana
O Podjetju
- Spletna Stran
- novonordisk.com
- Sektor
- Health Care · Biotechnology: Pharmaceutical Preparations
- Sedež
- BAGSVAERD DENMARK, Denmark
- Izvršni Direktor
- Maziar Mike Doustdar
- Zaposleni
- 66 700
- Delnice v Obtoku
- 3.34 mrd.
- Prosto Prenosljive Delnice
- 3.17 mrd.
- Tržna Kapitalizacija
- 150.93 mrd. EUR
- Notranje Osebe
- 5.27%
- Institucionalni Vlagatelji
- 33.78%
- Panoga (SIC)
- Pharmaceutical Preparations
- Pravna Oblika
- ZRPO
- ISIN
- DK0060534915
- LEI
- 549300DAQ1CVT6CXN342
- Delež Izplačila
- 50.5%
- FCF
- 59.0 mrd. DKK
- Izplačilo / FCF
- 88%
- Dolg
- 143 mrd. DKK2.0 let FCF
- Dividendni Staž
- 24 let
- Dobički, FCF in izplačane dividende — za 12 mesecev do 31.12.2025 (najnovejše poročilo podjetja).
Opis
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides NovoPen 6 and NovoPen Echo Plus, smart insulin pens; Dose Check, an insulin dose guidance application; growth hormone pens and injection needles; and Wegovy pill an oral glucagon-like peptide-1 (GLP-1) receptor agonist therapy for weight management. The company has a collaboration with Anthropic accelerate the development of new medicines and advance AI-driven software development. It operates in Europe, Canada, the United States, Japan, Korea, Oceania, Southeast Asia, Mainland China, Hong Kong and Taiwan, Latin America, the Middle East, and Africa. It has a strategic collaboration with Orbis Medicines to discover and develop oral macrocycle therapeutics for cardiometabolic diseases. The company was formerly known as Novo Industri A/S and changed its name to Novo Nordisk A/S in April 1989. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Dividende
Novo Nordisk A/S (NONOF) izplačuje dividende dvakrat letno. Na leto (12 mesecev do in vključno z najnovejšim napovedanim plačilom): 11.7 DKK na delnico (plačila: 2). Glede na zgodovino izplačil se naslednji datum ex-dividende pričakuje okoli 15.02.2027. Leta neprekinjenih dividend: 24.
| Ex-Datum | Izplačilo | Znesek | % | Vrsta | Oznaka |
|---|---|---|---|---|---|
| 2026-08-17 | 2026-08-18 | 3.7500 DKK | 1.2/3.9 % | polletno | US:NONOF |
| 2026-03-30 | 2026-03-31 | 7.9500 DKK | 3.4/5.0 % | polletno | US:NONOF |
| 2025-08-18 | 2025-08-19 | 3.7500 DKK | 1.1/3.4 % | polletno | US:NONOF |
| 2025-03-31 | 2025-04-01 | 7.9000 DKK | 1.7/2.5 % | polletno | US:NONOF |
| 2024-08-16 | 2024-08-19 | 3.5000 DKK | 1.4/3.8 % | polletno | US:NONOF |
| 2024-03-22 | 2024-03-26 | 6.4000 DKK | 2.5/≈5.0 % | polletno | US:NONOF |
Največji Imetniki
| Imetnik | Delež | Delnice | Datum Poročila |
|---|---|---|---|
| VANGUARD STAR FUNDS-Vang… | 1.38% | 46.88 mio. | 2026-07-31 |
| EuroPacific Growth Fund-… | 1.07% | 36.2 mio. | 2026-06-30 |
| VANGUARD TAX-MANAGED FUN… | 0.92% | 31.13 mio. | 2026-06-30 |
| Capital World Growth & I… | 0.77% | 26.02 mio. | 2026-06-30 |
| iShares Trust-iShares Co… | 0.71% | 24.13 mio. | 2026-08-31 |
| Income Fund of America | 0.52% | 17.78 mio. | 2026-07-31 |
| Dodge & Cox Funds-Dodge… | 0.39% | 13.1 mio. | 2026-06-30 |
| Fidelity Concord Street… | 0.37% | 12.52 mio. | 2026-07-31 |
| iShares Trust-iShares MS… | 0.34% | 11.48 mio. | 2026-08-31 |
| Capital Income Builder | 0.3% | 10.32 mio. | 2026-07-31 |
| Cygnus Capital Advisors,… | 0% | 78 800 | 2026-06-30 |
| Generali Investments Cee… | 0% | 27 399 | 2026-06-30 |
| Pacer Advisors, Inc. | 0% | 24 410 | 2026-06-30 |
| Atlas Capital Advisors I… | 0% | 5 218 | 2026-06-30 |
| Novo Holdings | — | — | — |
| Novo Nordisk Foundation | — | — | — |
